1. ELPIS II Missed Its Primary Efficacy Endpoint at Month 12:The trial recorded no significant difference in right ventricular ejection fraction, with a difference of -0.7 percentage points and a p-value of 0.8336.
1. Roth MKM Opens Coverage at Buy With a $6.00 Price Target:The initiation establishes the research house first published position on the stock rather than adjusting an existing view.
1. All-Stock Transaction Creates a Renamed Company Trading Under NRTX:The combinedBusinesswill operate as North Immunology with a pro formaEquityvaluation near $346.5 million.
1. Three-Party MOU Targets Non-Responding Relapsing-Remitting MS:The agreement brings together Tiziana (NASDAQ: TLSA), KAIMRC and the Foundation for Neurologic Diseases around a defined patient gap.
Abundia Global Impact (NYSE American:AGIG) Group has spent 2026 making a simple argument to the market: the technology to turn waste plastics into low-carbon fuels is no longer the hard part, building it and funding it is. That is why, for a company whose …
The Bank of Japan raised its policy rate 25 basis points to 1.25%, the highest since 1995, in a 7-2 vote with two reflectionist board members appointed by Prime Minister Sanae Takaichi dissenting toward a hold. The move marks a clear quickening in tightening, …
Viant Technology (NASDAQ:DSP) shares surged in Thursday's session after the company and a selling stockholder withdrew their previously launched secondary offering of 8.5 million Class A shares, just two days after the offering had pressured the stock lower into the mid-$10 range. Viant Technology …
Netflix (NASDAQ:NFLX) shares slid sharply in Thursday's session, extending a multi-month decline that has taken the stock well below its 200-dayMoving Averageand far from its 52-week high near $124.86. The pressure comes amid confirmation that Fox struck a deal to acquire Roku for $96 …
Schrödinger (NASDAQ:SDGR) shares eased in Thursday's session, giving back a small portion of the massive rally sparked by its Tectora Therapeutics deal announcement, which had driven shares up as much as 18% to 26% this week and near 52-week highs around $30. Schrödinger is …
Securitize (NYSE:SECZ) shares extended their rally further in Thursday's session as the SEC's landmark Innovation Exemption continued to reshape investor expectations for the tokenization industry. The five-year exemption allows qualifying blockchain-based platforms to trade tokenized representations of U.S. equities outside the traditional exchange framework, …